These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 13409282)

  • 1. Tyrosinase activity in the cellular fractions of Harding-Passey melanoma.
    ROBERTSON CH; BERGENDAHL JC; ADAMS EC
    Tex Rep Biol Med; 1957; 15(1):78-83. PubMed ID: 13409282
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metastatic ability of Harding-Passey melanoma].
    LLAMBES JJ; GARCIA MENDEZ J
    Arch Cuba Cancerol; 1953; 12(10-11-12):246-52. PubMed ID: 13139966
    [No Abstract]   [Full Text] [Related]  

  • 3. [Oxidation of thyronine and of certain of its iodized derivatives by Harding-Passey melanoma].
    LISSITZKY S; BOUCHILLOUX S; MAYRARGUE-KODJA A
    C R Seances Soc Biol Fil; 1957; 151(2):350-2. PubMed ID: 13473267
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of pigment fractions from Harding-Passey melanoma].
    Malama AA
    Vopr Onkol; 1973; 19(1):75-7. PubMed ID: 4701928
    [No Abstract]   [Full Text] [Related]  

  • 5. Harding-Passey melanoma, obob genotype, age, and high environmental temperature as modifiers of the anaerobic glycolytic capacity of mouse kidneys.
    WOLFF GL
    J Natl Cancer Inst; 1956 Apr; 16(5):1249-55. PubMed ID: 13307252
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy of Harding-Passey melanoma.
    SUGIURA K
    Ann N Y Acad Sci; 1963 Feb; 100():334-47. PubMed ID: 13979139
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of transplantable Harding-Passey melanoma in the gel precipitation reaction].
    BASHKAEV IS; ROZENBAUM GI
    Vopr Onkol; 1963; 9(2)():83-7. PubMed ID: 13969837
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytological studies on the nature of the cytoplasmic particulates in the Cloudman S91 mouse melanoma, the derived Algire S91A partially amelanotic melanoma, and the Harding-Passey mouse melanoma.
    WOODS MW; DuBUY HG; HESSELBACH ML
    J Natl Cancer Inst; 1949 Feb; 9(4):311-23. PubMed ID: 18112038
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental studies on the granule of the Harding-Passey melanoma in mice].
    GRUETZ O; WOEBER K
    Arch Klin Exp Dermatol; 1962; 214():346-61. PubMed ID: 13902408
    [No Abstract]   [Full Text] [Related]  

  • 10. Some physiologic relationships between the obese (obob) genotype of the mouse and the Harding-Passey melanoma.
    WOLFF GL
    J Natl Cancer Inst; 1956 Apr; 16(5):1231-47. PubMed ID: 13307251
    [No Abstract]   [Full Text] [Related]  

  • 11. Action of p-[di(2-chloroethyl)]-amino-l-phenylalanine on Harding-Passey mouse melanoma.
    LUCK JM
    Science; 1956 Jun; 123(3205):984-5. PubMed ID: 13324127
    [No Abstract]   [Full Text] [Related]  

  • 12. [Free radicals in Harding-Passey melanoma after irradiation with unfocused laser ray].
    Piruzian LA; Barsegian LKh; Dement'ev VA; Savchenko GS
    Izv Akad Nauk SSSR Biol; 1968; 1():121-3. PubMed ID: 5662663
    [No Abstract]   [Full Text] [Related]  

  • 13. [Appearance of homovanillic acid and vannillactic acid in the urine of mice with transplantable Harding-Passey melanoma].
    Procházková B; Duchon J
    Cas Lek Cesk; 1970 Feb; 109(6):147-50. PubMed ID: 5413522
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma.
    Sato K; Toriyama M
    J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the possible effect of radioactive iodide on the protein synthesis of Harding-Passey mouse melanoma. I. In vivo experiments.
    SALO T; BLAIR B
    Cancer Res; 1960 Oct; 20():1292-8. PubMed ID: 13745717
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic efficacy of antigen-specific vaccination and toll-like receptor stimulation against established transplanted and autochthonous melanoma in mice.
    Tormo D; Ferrer A; Bosch P; Gaffal E; Basner-Tschakarjan E; Wenzel J; Tüting T
    Cancer Res; 2006 May; 66(10):5427-35. PubMed ID: 16707471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-tyrosinase activity of the serum: preliminary note on the possibility of serodiagnosis of malignant melanoma].
    GRUPPER C
    Bull Soc Fr Dermatol Syphiligr; 1954; 61(2):145-7. PubMed ID: 13199603
    [No Abstract]   [Full Text] [Related]  

  • 18. Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells.
    Rad HH; Yamashita T; Jin HY; Hirosaki K; Wakamatsu K; Ito S; Jimbow K
    Exp Cell Res; 2004 Aug; 298(2):317-28. PubMed ID: 15265682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and characterization of a therapeutic human antibody to melanoma antigen TYRP1.
    Patel D; Balderes P; Lahiji A; Melchior M; Ng S; Bassi R; Wu Y; Griffith H; Jimenez X; Ludwig DL; Hicklin DJ; Kang X
    Hum Antibodies; 2007; 16(3-4):127-36. PubMed ID: 18334748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potent tyrosinase activator from Radix Polygoni multiflori and its melanogenesis stimulatory effect in B16 melanoma cells.
    Guan S; Su W; Wang N; Li P; Wang Y
    Phytother Res; 2008 May; 22(5):660-3. PubMed ID: 18389468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.